Clinical Trial Update: Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate efficacy and safety of AGE ZERO EXOSOMES for treating androgenetic alopecia in men and women; the study is currently not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• AGE ZERO EXOSOMES

Snippet

Sponsor: Levit Dermatology | Conditions: Androgenetic Alopecia | Phase 1 | Status: NOT_YET_RECRUITING